Tell us what you need and we'll tell you how we can help.
Dr Sally Ann became CEO of Stevenage Bioscience Catalyst (SBC) on 5th March 2018 with the aim of developing SBC to its full potential as a world class science, innovation and business cluster. Before coming to SBC, Sally Ann was CEO of Norwich Research Park, a life science cluster of world... read more
Colin Anderson was appointed Chief Financial Officer in May 2013. Colin has been part of the SBC management team since its inception in 2010, when he was seconded to the role of Business Operations Director from GlaxoSmithKline. During this time he worked closely with the SBC Board to help... read more
Dave Mudd joined the Stevenage Bioscience Catalyst team in August 2011, becoming Buildings and Operations Manager in June 2012. He has worked extensively in supply chain and operations management, particularly focusing on distribution. Areas of expertise include management of staff and... read more